IL151031A0 - Compounds with chelation affinity and selectivity for first transition series elements and their use - Google Patents

Compounds with chelation affinity and selectivity for first transition series elements and their use

Info

Publication number
IL151031A0
IL151031A0 IL15103101A IL15103101A IL151031A0 IL 151031 A0 IL151031 A0 IL 151031A0 IL 15103101 A IL15103101 A IL 15103101A IL 15103101 A IL15103101 A IL 15103101A IL 151031 A0 IL151031 A0 IL 151031A0
Authority
IL
Israel
Prior art keywords
series elements
transition series
compounds
inhibition
decrease
Prior art date
Application number
IL15103101A
Other languages
English (en)
Original Assignee
Concat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concat Ltd filed Critical Concat Ltd
Publication of IL151031A0 publication Critical patent/IL151031A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL15103101A 2000-02-22 2001-02-14 Compounds with chelation affinity and selectivity for first transition series elements and their use IL151031A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/510,134 US6264966B1 (en) 2000-02-22 2000-02-22 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
PCT/US2001/004977 WO2001062262A1 (en) 2000-02-22 2001-02-14 Compounds with chelation affinity and selectivity for first transition series elements and their use

Publications (1)

Publication Number Publication Date
IL151031A0 true IL151031A0 (en) 2003-04-10

Family

ID=24029507

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15103101A IL151031A0 (en) 2000-02-22 2001-02-14 Compounds with chelation affinity and selectivity for first transition series elements and their use
IL151031A IL151031A (en) 2000-02-22 2002-08-01 Cosmetics or body care products to prevent body odors that contain a complexion factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151031A IL151031A (en) 2000-02-22 2002-08-01 Cosmetics or body care products to prevent body odors that contain a complexion factor

Country Status (10)

Country Link
US (2) US6264966B1 (enExample)
EP (2) EP1261349B1 (enExample)
JP (1) JP2003523394A (enExample)
AT (1) ATE406902T1 (enExample)
AU (1) AU2001237038A1 (enExample)
CA (1) CA2399299C (enExample)
DE (2) DE01909263T1 (enExample)
ES (1) ES2239924T1 (enExample)
IL (2) IL151031A0 (enExample)
WO (1) WO2001062262A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
MXPA02006338A (es) 1999-12-24 2002-12-13 Aventis Pharma Ltd Azaindoles.
US6264966B1 (en) * 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
US6881732B2 (en) * 2002-06-13 2005-04-19 Chelator Llc Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements
EP1620066A4 (en) * 2003-05-07 2010-11-03 Dmi Biosciences Inc ORAL CARE PROCESSES AND PRODUCTS
US20050112066A1 (en) * 2003-11-26 2005-05-26 Concat Lp, A California Limited Partnership Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
US7659233B2 (en) * 2004-10-25 2010-02-09 Conopco, Inc. Personal care compositions with silicones and dihydroxypropyl trialkyl ammonium salts
US8476251B2 (en) 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN103086922A (zh) * 2013-02-07 2013-05-08 东华大学 一种n-烷氧基-4-戊烯酰胺类化合物及其制备方法
KR101709124B1 (ko) * 2015-08-19 2017-02-22 기초과학연구원 신규한 키랄 금속 착물 및 분광법에 의해 전하를 띤 화합물의 키랄성을 분석하기 위한 이의 용도
EP3390348B1 (en) 2015-12-16 2024-04-17 Loveland Products, Inc. Dendrimer and formulations thereof
JP7191938B2 (ja) 2017-05-05 2022-12-19 センター・フォー・プローブ・デベロップメント・アンド・コマーシャライゼイション Ｉｇｆ－１ｒモノクローナル抗体及びその使用
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
RU2019139432A (ru) 2017-05-05 2021-06-07 Сентр фор Проуб Девелопмент энд Коммерсиализэйшн Фармакокинетическая оптимизация бифункциональных хелатов и их применение
US11373803B2 (en) 2017-08-11 2022-06-28 Applied Materials, Inc. Method of forming a magnetic core on a substrate
WO2020102820A1 (en) 2018-11-16 2020-05-22 The Research Foundation For The State University Of New York Compounds for use as iron (iii) mri contrast agents containing anionic pendents and ancillary groups

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356190A (en) * 1974-06-12 1982-10-26 Personal Products Company Inhibiting production of undesirable products on body surfaces and environs employing aminopolycarboxylic compounds
JPS62238213A (ja) * 1986-04-04 1987-10-19 Maab:Kk 脱臭用清浄布収納パツク
JPH0825861B2 (ja) * 1989-04-24 1996-03-13 サンスター株式会社 歯磨組成物
US5236695A (en) 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
WO1993011741A1 (en) * 1991-12-10 1993-06-24 The Dow Chemical Company Oral compositions for inhibiting plaque and calculus formation
US5409689A (en) 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP0841951A2 (en) 1995-06-26 1998-05-20 Concat Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
FR2737204B1 (fr) * 1995-07-26 1997-09-12 Oreal Derives de n,n'-di(aralkyl)n,n'-di(carboxylakyl)alkylene di- ou triamine et de n-(aralkyl)n'-(carboxyalkyl) n,n'-di(carboxyalkyl)alkylene di- ou triamine et leur utilisation en pharmacie et en cosmetique
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US6165966A (en) * 1996-09-24 2000-12-26 The Procter & Gamble Company Liquid detergents containing proteolytic enzyme and protease inhibitors
DE60129791T2 (de) * 2000-01-18 2008-04-30 Unilever N.V. Antimikrobielle zubereitung salz eines übergangmetall-chelators enthaltend
GB0001129D0 (en) * 2000-01-18 2000-03-08 Unilever Plc Anti-microbial aerosol compositions
US6264966B1 (en) * 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury

Also Published As

Publication number Publication date
EP1261349B1 (en) 2008-09-03
DE01909263T1 (de) 2004-08-26
AU2001237038A1 (en) 2001-09-03
CA2399299C (en) 2009-11-17
EP1261349A1 (en) 2002-12-04
EP1261349A4 (en) 2004-09-01
IL151031A (en) 2009-06-15
US6264966B1 (en) 2001-07-24
CA2399299A1 (en) 2001-08-30
US6387891B2 (en) 2002-05-14
US20010041170A1 (en) 2001-11-15
DE60135638D1 (de) 2008-10-16
EP2011501A1 (en) 2009-01-07
WO2001062262A1 (en) 2001-08-30
ATE406902T1 (de) 2008-09-15
ES2239924T1 (es) 2005-10-16
JP2003523394A (ja) 2003-08-05

Similar Documents

Publication Publication Date Title
IL151031A0 (en) Compounds with chelation affinity and selectivity for first transition series elements and their use
Addy Chlorhexidine compared with other locally delivered antimicrobials: a short review
WO2003043517A3 (en) Dentifrice compositions
AR034300A1 (es) Metodos para mejorar la higiene dental animal
CA2613509A1 (en) Carrier strip for application to oral surfaces and related methods
RU2012108729A (ru) Композиция для ухода за полостью рта
AU2007338828B2 (en) Anti-calculus dental composition and methods for using same
DK321787D0 (da) Usninsyrepraeparater
JP2003523394A5 (enExample)
PT966256E (pt) Produto para a higiene e saude bucais
ES2648218T3 (es) Procedimientos de mantenimiento de la higiere oral en animales utilizando derivados de morfolina
ATE138558T1 (de) Phytat-antimicrobielle zusammensetzungen in mundpflegemitteln
BRPI0411521A (pt) composição de alimento para animais de estimação
GR950100243A (el) Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
PE103198A1 (es) Composiciones antimicrobianas para el cuidado bucal y composiciones para el tratamiento de la enfermedad periodontal y el mal olor del aliento
DE60206476D1 (de) Remineralisierendes zahnpflegemittel
ATE370724T1 (de) Mundpflegemittel enthaltend einen fluor-ion- vektor und ein antioxidationsmittel
MX243373B (es) Uso de una cepa de bacterias lacticas exogenas contra enfermedades relacionadas con actinomyces naeslundii.
CA2626099A1 (en) Oral composition containing morin
PE102898A1 (es) Composiciones antimicrobianas para el cuidado bucal y composiciones para el tratamiento de la enfermedad periodontal y el mal olor del aliento
CA2547654A1 (en) Use of osteopontin in dental formulations
Nguyen et al. Evaluation and Comparison of Patient Feedback on Chlorhexidine Vs Anti-Calculus Mouthrinse after 6 Months of Compliance
Hunt Dental Care
Nagelberg UNDERSTANDING ADVANCES IN ORAL RINSE TECHNOLOGIES.
MXPA02008502A (es) Preparaciones para la higiene oral, antiplaca y antibacteriana que contienen aceite de oliva.